Log In
BCIQ
Print this Print this
 

ACH-4471

  Manage Alerts
Collapse Summary General Information
Company Achillion Pharmaceuticals Inc.
DescriptionComplement factor D (CFD; adipsin) inhibitor
Molecular Target Complement factor D (CFD) (adipsin)
Mechanism of ActionComplement inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Hematology (unspecified)
Indication DetailsTreat complement-mediated diseases
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today